Elevated helicobacter pylori prevalence in patients receiving TNF-α blocker therapy for inflammatory bowel disease

The aim of this retrospective study was to investigate the prevalence of Helicobacter pylori (H. pylori) in patients with ulcerative colitis or Crohn's disease who received TNF-α blocker therapy compared to a control group and to evaluate H. pylori as a potential side effect of TNF-α inhibi...

Full description

Bibliographic Details
Main Authors: Ali Muhtaroglu, Furkan Ali Uygur, Ahmet Cumhur Dulger
Format: Article
Language:English
Published: Society of Turaz Bilim 2023-06-01
Series:Medicine Science
Subjects:
Online Access:https://www.medicinescience.org/?mno=145921